Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Thomas M. Salus has been appointed vice president, contract services, Avéma Pharma Solutions, a division of PL Developments, and Richard Thome has been named senior vice president, operations of both PL Developments and Avéma Pharma Solutions. 
   
Mr. Salus will be responsible for managing and expanding sales of contract manufacturing and packaging services provided by Avéma and PL Developments. Mr. Salus has industry experience that includes sales and marketing positions at Applied Analytical Industries (AAI), Banner Pharmacaps, Glatt Pharmaceutical Services, and Norwich Pharmaceuticals.
   
John Francis, Avema’s senior vice president of sales and global business development, said, “Tom brings 14 years of pharmaceutical contract services sales experience to Avéma Pharma Solutions. His knowledge of the pharmaceutical contract manufacturing and product development marketplace will allow our organization to best maximize the services and capacities in both our Miami, FL and Westbury, NY locations. We look forward to Tom’s effort and customer service focus, in the area of contract manufacturing, to compliment the success of our private-label business.”
     
Mr. Thome’s responsibilities include overall operational management for the facilities in NY and FL. His industry experience includes positions at Orange Glo International, Prestige Brands, Pall Corp., Omega Pharmaceuticals and Kingsford, a division of Clorox. 
   
Mitch Singer, the company’s president and chief executive officer, said, “With the continued growth of our private label business, plus the acquisition of Avéma Pharma Solutions in Miami, FL, we needed to take advantage of the synergies and the cross-plant efficiencies. Richard’s 33 years of operational experience and OTC / CPG / Nutraceutical industry background, plus his strong commitment to customer service and cost control, will allow PL Developments to build on industry best practices and help establish a stronger platform for continued growth.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters